Given its relevance to our ongoing clinical trial evaluating the anti-tumor effects of adoptive transfer of ex vivo expanded NK cells, we next evaluated the impact of multiple different NK cell manipulations on CXCR4 expression including cryopreservation and thawing, IL-2 activation, and ex vivo expansion. The gene discussed is IL2; the disease is neoplasm.